Drug Injury Watch: July 2013 Update: New FDA Action To Be Taken In Or About September On Issue Of Dr
Drug Injury Watch: July 2013 Update: New FDA Action To Be Taken In Or About September On Issue Of Drug Label Revisions By Generic Manufacturers Allowing Supplemental Applications For Proposed Labeling Changes Might End Federal Preemption Shield From Legal Liability That Came With Mensing Ruling http://www.drug-injury.com/druginjurycom/2013/07/fda-action-generic-drugs-label-revisions-non-brand-name-manufacturers-regulations-proposed-rulemaking-notice-omb.html
Contributor
About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.
Related Documents in Personal Injury
- Drug Injury Watch: Depacon / Depakene / Depakote: 400% Increased Risk Of Birth Defects Compared To O
- Drug Injury Watch: Levaquin / Cipro / Avelox: Retinal Detachments Are Visual Side Effects Of Oral Fl
- Drug Injury Watch: Levaquin / Cipro / Avelox: Small But Significant Increased Risk Of Acute Kidney I
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4